Beyond Trial Dashboard

Dummy Project

PED-ABX-09

Pediatric dosing, safety, consent, and inspection contrast.

Pediatric/Infectious DiseasePhase II/IIIPediatric antibioticInitiating, Planning, Executing, Monitoring, Closing

Project Story

What readers should notice

PED-ABX-09 is written as a case a working PM can recognize, not as a sterile protocol summary. The project sits in Pediatric/Infectious Disease as a Pediatric antibiotic study, but the real teaching point is this: pediatric dosing, consent, safety escalation, formulation logistics, and site workflow must be simple enough to execute under real family and clinic pressure. When readers compare PED-ABX-09 with their own project, they should look for the same pressure points: what the protocol assumes, what sites can actually do, what vendors must prove, what data must remain credible, what safety or ethics concern could change the plan, and what Daniel Liang's team would ask before accepting a green dashboard as truth.

Lifecycle Coverage

Book Mentions

How to read this case

Look for the moment when ordinary project language stops being enough: a date slips, an assumption fails, a vendor signal loses meaning, or a clinical concern changes the work. Then follow the chapter links, toolkit examples, glossary terms, and packet artifacts to compare this fictional pressure pattern with a real project you manage.

Initiation Packet